{"id":4607210389617,"title":"FoundationOne CDx","handle":"foundationone-cdx","description":"\u003cp\u003eFoundationOne CDx is the first FDA-approved tissue-based broad companion diagnostic (CDx) that is clinically and analytically validated for all solid tumors. The test is designed to provide physicians with clinically actionable information — both to consider appropriate therapies for patients and understand results with evidence of resistance — based on the individual genomic profile of each patient’s cancer.  \u003c\/p\u003e\n","published_at":"2020-11-09T09:20:24-08:00","created_at":"2020-11-05T13:36:34-08:00","vendor":"Foundation Medicine","type":"Test Kits","tags":["age_Adult","age_Senior","brand_id_188","brand_name_foundation-medicine","clinic_membership_price_0.00","clinic_regular_price_0.00","clinic_subscription_price_0.00","clinical_kits","country_united-states-of-america","custom_mip_5800","custom_msrp_5800","diagnostic_in_clinic","display_on_sort_page","do_not_track_inventory","gender_Female","gender_Male","health_Internal-Health","healthconcerns_Cancer-Support---Before-Treatment","immune_health","mip_5800.00","mrp_0.00","msrp_5800.00","package_id_103","packagename_Kit","physical_product","primary_category_id_109","primary_category_name_test-kits","product_name_foundationone-cdx","recommendation_421___cancer_before_","recommendation_42___cancer","sale_channel_2_add_to_cart_logged-user","sale_channel_2_display_price_logged-user","sale_channel_2_display_product_logged-user","sale_channel_clinic","sale_channel_shopify-us_Shopify US","shopify_us_membership_price_0.00","shopify_us_regular_price_5800.00","shopify_us_subscription_price_5800.00","sku_FM-CDX-I4-SD","use_custom_prices","useIngredientsimage","vendor_id_158","vendor_link_https:\/\/www.foundationmedicine.com\/test\/foundationone-cdx","vendor_name_foundation-medicine"],"price":580000,"price_min":580000,"price_max":580000,"available":true,"price_varies":false,"compare_at_price":580000,"compare_at_price_min":580000,"compare_at_price_max":580000,"compare_at_price_varies":false,"variants":[{"id":32170191388785,"title":"Default Title","option1":"Default Title","option2":null,"option3":null,"sku":"FM-CDX-I4-SD","requires_shipping":true,"taxable":true,"featured_image":null,"available":true,"name":"FoundationOne CDx","public_title":null,"options":["Default Title"],"price":580000,"weight":0,"compare_at_price":580000,"inventory_management":null,"barcode":""}],"images":["\/\/cdn.shopify.com\/s\/files\/1\/0178\/1763\/2868\/products\/FM-CDX-I4-SD-FoundationOne_20CDx-1_4e055896-d495-4697-bdcc-68f8f336fb3d.png?v=1614903155"],"featured_image":"\/\/cdn.shopify.com\/s\/files\/1\/0178\/1763\/2868\/products\/FM-CDX-I4-SD-FoundationOne_20CDx-1_4e055896-d495-4697-bdcc-68f8f336fb3d.png?v=1614903155","options":["Title"],"media":[{"alt":"FM-CDX-I4-SD FoundationOne CDx","id":20309262172273,"position":1,"preview_image":{"aspect_ratio":1.333,"height":675,"width":900,"src":"https:\/\/cdn.shopify.com\/s\/files\/1\/0178\/1763\/2868\/products\/FM-CDX-I4-SD-FoundationOne_20CDx-1_4e055896-d495-4697-bdcc-68f8f336fb3d.png?v=1614903155"},"aspect_ratio":1.333,"height":675,"media_type":"image","src":"https:\/\/cdn.shopify.com\/s\/files\/1\/0178\/1763\/2868\/products\/FM-CDX-I4-SD-FoundationOne_20CDx-1_4e055896-d495-4697-bdcc-68f8f336fb3d.png?v=1614903155","width":900}],"content":"\u003cp\u003eFoundationOne CDx is the first FDA-approved tissue-based broad companion diagnostic (CDx) that is clinically and analytically validated for all solid tumors. The test is designed to provide physicians with clinically actionable information — both to consider appropriate therapies for patients and understand results with evidence of resistance — based on the individual genomic profile of each patient’s cancer.  \u003c\/p\u003e\n"}

FoundationOne CDx

Membership required to purchase: Login or submit an application to become our member.

$5,800.00

FoundationOne CDx is the first FDA-approved tissue-based broad companion diagnostic (CDx) that is clinically and analytically validated for all solid tumors. The test is designed to provide physicians with clinically actionable information — both to consider appropriate therapies for patients and understand results with evidence of resistance — based on the individual genomic profile of each patient’s cancer.  

Sku : FM-CDX-I4-SD

Related Products



Test results include microsatellite instability (MSI) and tumor mutational burden (TMB) to help inform immunotherapy decisions, and loss of heterozygosity (LOH) for ovarian cancer patients. You can also order PD-L1 immunohistochemistry (IHC) testing* as an optional add-on test. We offer the option to reflex from FoundationOne CDx testing to FoundationOne®Liquid CDx if the tissue submitted does not meet the criteria for successful testing. 

FoundationOne CDx has national coverage for qualifying Medicare and Medicare Advantage patients across all solid tumors.